Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Change in Accured Expenses: 2010-2019

Historic Change in Accured Expenses for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to $2.2 million.

  • EyePoint Pharmaceuticals' Change in Accured Expenses rose 160.98% to $2.2 million in Q4 2019 from the same period last year, while for Dec 2019 it was $1.9 million, marking a year-over-year increase of 673.08%. This contributed to the annual value of $5.7 million for FY2024, which is 277.29% up from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Change in Accured Expenses stood at $2.2 million for Q4 2019, which was down 14.89% from $2.6 million recorded in Q1 2019.
  • EyePoint Pharmaceuticals' 5-year Change in Accured Expenses high stood at $2.7 million for Q2 2018, and its period low was -$3.6 million during Q4 2018.
  • Its 3-year average for Change in Accured Expenses is $341,000, with a median of $297,000 in 2017.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Change in Accured Expenses soared by 18,060.00% in 2015, and later crashed by 630.30% in 2017.
  • Over the past 5 years, EyePoint Pharmaceuticals' Change in Accured Expenses (Quarterly) stood at $898,000 in 2015, then plummeted by 88.98% to $99,000 in 2016, then plummeted by 630.30% to -$525,000 in 2017, then slumped by 589.33% to -$3.6 million in 2018, then surged by 160.98% to $2.2 million in 2019.
  • Its last three reported values are $2.2 million in Q4 2019, $2.6 million for Q1 2019, and -$3.6 million during Q4 2018.